News coverage about Wright Medical Group N.V. (NASDAQ:WMGI) has trended positive recently, Accern Sentiment Analysis reports. The research firm identifies negative and positive media coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Wright Medical Group N.V. earned a news sentiment score of 0.44 on Accern’s scale. Accern also gave media headlines about the medical device company an impact score of 45.7595951947317 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.
These are some of the news stories that may have effected Accern Sentiment’s scoring:
- Wright Medical (WMGI) Rides on Strong Portfolio & Innovation (finance.yahoo.com)
- Wright Medical Group N.V. (WMGI) Given Average Recommendation of “Buy” by Analysts (americanbankingnews.com)
- Contrasting Wright Medical Group N.V. (WMGI) & Delcath Systems (DCTHD) (americanbankingnews.com)
- Critical Contrast: Wright Medical Group N.V. (WMGI) & Delcath Systems (DCTHD) (americanbankingnews.com)
- $221.96 Million in Sales Expected for Wright Medical Group N.V. (WMGI) This Quarter (americanbankingnews.com)
A number of equities analysts have recently commented on WMGI shares. Oppenheimer Holdings, Inc. set a $30.00 price target on shares of Wright Medical Group N.V. and gave the stock a “hold” rating in a report on Thursday, August 3rd. Piper Jaffray Companies reissued a “buy” rating and issued a $34.00 price target on shares of Wright Medical Group N.V. in a report on Thursday, August 3rd. Jefferies Group LLC reissued a “buy” rating and issued a $33.00 price target on shares of Wright Medical Group N.V. in a report on Friday, August 4th. BidaskClub lowered shares of Wright Medical Group N.V. from a “hold” rating to a “sell” rating in a report on Saturday, August 5th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Wright Medical Group N.V. in a report on Friday, September 1st. Six investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. Wright Medical Group N.V. presently has a consensus rating of “Buy” and an average target price of $32.22.
Wright Medical Group N.V. (NASDAQ:WMGI) last posted its earnings results on Wednesday, November 1st. The medical device company reported ($0.16) EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of ($0.16). Wright Medical Group N.V. had a negative net margin of 38.40% and a negative return on equity of 6.27%. The firm had revenue of $170.50 million during the quarter, compared to analysts’ expectations of $173.50 million. During the same period last year, the company posted ($0.19) EPS. The company’s quarterly revenue was up 8.4% compared to the same quarter last year. research analysts forecast that Wright Medical Group N.V. will post -0.27 earnings per share for the current year.
In other Wright Medical Group N.V. news, Director Richard F. Wallman purchased 4,000 shares of the stock in a transaction that occurred on Friday, November 10th. The stock was bought at an average cost of $24.00 per share, with a total value of $96,000.00. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, SVP Gregory Morrison sold 92,140 shares of Wright Medical Group N.V. stock in a transaction dated Monday, November 13th. The shares were sold at an average price of $23.70, for a total transaction of $2,183,718.00. The disclosure for this sale can be found here. Over the last three months, insiders have sold 92,440 shares of company stock valued at $2,191,500. 3.50% of the stock is currently owned by corporate insiders.
About Wright Medical Group N.V.
Wright Medical Group, Inc is a global specialty orthopaedic company. The Company through Wright Medical Technology, Inc (WMT) and other subsidiaries provides extremity and biologic solutions that enable clinicians to alleviate pain and restore the patients’ lifestyles. The Company operates through three segments: U.S., International and BioMimetic.
Receive News & Ratings for Wright Medical Group N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wright Medical Group N.V. and related companies with MarketBeat.com's FREE daily email newsletter.